BUSINESSFDA approves label changes for Emmaus’ sickle cell treatment Sri Surya Drishti5 days ago01 mins Follow ( 0 Followers ) XFollow E-mail : * Post Content News Views: 3Post navigationPrevious: Schwab Fundamental International Small Equity ETF declares $0.1942 dividendNext: Ambipar stock hits 52-week high at 4.3 USDLeave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment *Name * Email * Website Save my name, email, and website in this browser for the next time I comment.
Stock futures signal fresh highs as tax cuts advance in Senate while Trump balks at extending tariff deadline Sri Surya Drishti23 hours ago 0
Top stocks to buy: Stock recommendations for the week starting June 30, 2025 – check list Sri Surya Drishti23 hours ago 0
Mumbai urban push: Dharavi to get commercial business district; project eyes economic uplift, employment boost Sri Surya Drishti23 hours ago 0
Asian markets show optimism: Stocks steady as US-Canada trade talks progress; eye on US jobs data due this week Sri Surya Drishti23 hours ago 0
